CNY 17.1
(-0.52%)
Year | Operating Income | Operating Income Growth |
---|---|---|
2023 | 718.17 Million CNY | 12.3% |
2022 | 639.52 Million CNY | -6.03% |
2021 | 680.58 Million CNY | 17.73% |
2020 | 578.09 Million CNY | 24.09% |
2019 | 465.85 Million CNY | 1.36% |
2018 | 459.57 Million CNY | 10.98% |
2017 | 414.1 Million CNY | 18.07% |
2016 | 350.72 Million CNY | 15.13% |
2015 | 304.64 Million CNY | 2.75% |
2014 | 296.47 Million CNY | 5.63% |
2013 | 280.67 Million CNY | 5.29% |
2012 | 266.58 Million CNY | 34.6% |
2011 | 198.05 Million CNY | 0.0% |
Year | Operating Income | Operating Income Growth |
---|---|---|
2024 Q1 | 89.85 Million CNY | 10.67% |
2024 Q3 | 465.33 Million CNY | 4151.9% |
2024 Q2 | -11.48 Million CNY | -112.78% |
2023 Q2 | 22.22 Million CNY | -76.91% |
2023 Q4 | 81.18 Million CNY | -84.34% |
2023 FY | 718.17 Million CNY | 12.3% |
2023 Q1 | 96.28 Million CNY | 48.7% |
2023 Q3 | 518.47 Million CNY | 2232.52% |
2022 FY | 639.52 Million CNY | -6.03% |
2022 Q4 | 64.75 Million CNY | -87.24% |
2022 Q3 | 507.42 Million CNY | 87282.63% |
2022 Q2 | -582.02 Thousand CNY | -100.88% |
2022 Q1 | 65.84 Million CNY | -56.76% |
2021 Q1 | 58.61 Million CNY | -56.26% |
2021 Q4 | 152.28 Million CNY | -68.58% |
2021 Q3 | 484.67 Million CNY | 3333.31% |
2021 FY | 680.58 Million CNY | 17.73% |
2021 Q2 | -14.99 Million CNY | -125.57% |
2020 Q3 | 424.19 Million CNY | 16691.16% |
2020 FY | 578.09 Million CNY | 24.09% |
2020 Q4 | 134.01 Million CNY | -68.41% |
2020 Q2 | 2.52 Million CNY | -85.44% |
2020 Q1 | 17.35 Million CNY | -75.82% |
2019 Q4 | 71.76 Million CNY | -76.84% |
2019 Q3 | 309.91 Million CNY | 1075.28% |
2019 FY | 465.85 Million CNY | 1.36% |
2019 Q1 | 57.8 Million CNY | -44.31% |
2019 Q2 | 26.36 Million CNY | -54.38% |
2018 Q2 | 20.85 Million CNY | -58.47% |
2018 Q1 | 50.21 Million CNY | -67.06% |
2018 FY | 459.57 Million CNY | 10.98% |
2018 Q4 | 103.8 Million CNY | -63.54% |
2018 Q3 | 284.7 Million CNY | 1265.3% |
2017 Q3 | 209.72 Million CNY | 1246.09% |
2017 Q1 | 36.36 Million CNY | -70.47% |
2017 Q2 | 15.58 Million CNY | -57.16% |
2017 FY | 414.1 Million CNY | 18.07% |
2017 Q4 | 152.44 Million CNY | -27.31% |
2016 Q2 | 12.55 Million CNY | -40.5% |
2016 Q3 | 193.93 Million CNY | 1444.58% |
2016 Q1 | 21.1 Million CNY | 0.0% |
2016 FY | 350.72 Million CNY | 15.13% |
2016 Q4 | 123.13 Million CNY | -36.51% |
2015 FY | 304.64 Million CNY | 2.75% |
2014 Q1 | 14.1 Million CNY | 0.0% |
2014 FY | 296.47 Million CNY | 5.63% |
2014 Q4 | 130.62 Million CNY | 0.0% |
2014 Q3 | 130.62 Million CNY | 826.24% |
2014 Q2 | 14.1 Million CNY | 0.0% |
2013 FY | 280.67 Million CNY | 5.29% |
2012 FY | 266.58 Million CNY | 34.6% |
2011 FY | 198.05 Million CNY | 0.0% |
Name | Operating Income | Operating Income Difference |
---|---|---|
Xinjiang Bai Hua Cun Pharma Tech Co.,Ltd | 17.95 Million CNY | -3899.655% |